| Application no. and date | 16163440.7 (espacenet) (Federated) (European Patent Register), 20111104 | | Patent/reg. no. and date | DK/EP 3111954, 20190403 | | Publication date | 20170104 | | Priority no. and date | US 410533 P, 20101105 | | EP pub. no. and date |
EP 3111954 20170104 | | Effective date | | | Applicant/owner | NOVARTIS AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | SH/GP/158754 | | Inventor | MPOFU, Shepard, Novartis Pharma AG
Postfach
4002 Basel, CH,
RICHARDS, Hanno, Novartis Pharma AG
Postfach
4002 Basel, CH,
THANGAVELU, Karthinathan, Novartis Pharma AG
Postfach
4002 Basel, CH,
MACHACEK, Matthias, Novartis Pharma AG
Postfach
4002 Basel, CH | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/519 (2006.01) , A61K 39/395 (2006.01) , A61P 37/06 (2006.01) , C07K 16/24 (2006.01) | | Title | Fremgangsma?der til behandling af ankyloserende spondylitis ved anvendelse af anti-IL-17-antistoffer | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
